ijms-logo

Journal Browser

Journal Browser

New Insights into the Tumor Microenvironment of Pleural Mesothelioma and Opportunities for Novel Treatments

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".

Deadline for manuscript submissions: 31 January 2026 | Viewed by 3

Special Issue Editor


E-Mail Website
Guest Editor
Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy
Interests: cancer; molecular oncology; molecular medicine; targeted therapy; cell signaling; pulmonary diseases
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Pleural mesothelioma (PM) is the main cancer affecting the pleural membranes covering the lungs. It is characterized by high heterogeneity, a lack of markers for early diagnosis, and actionable targets for effective therapeutic strategies.

For the past 15 years, the combination of cisplatin or carboplatin with pemetrexed has remained the standard-of-care for patients with unresectable PM. Recently, the introduction of immune checkpoint inhibitors (ICIs) has revolutionized the previously static therapeutic landscape for PM, and numerous clinical trials are currently underway to evaluate the benefits of new combination regimens. However, the prognosis for patients with PM remains poor.

Beyond the immune cells, growing evidence is highlighting the critical roles of other cellular populations in the tumor microenvironment (TME) involved in immunosuppression and chemoresistance. These include Cancer-Associated Fibroblasts (CAFs), Endothelial Cells, Cancer-Associated Adipocytes (CAAs), and Mesenchymal Stromal Cells (MSCs).

These cells mediate their effects through secreting inhibitory cytokines, nitric oxide, and damage- or pathogen-associated molecular patterns, as well as through direct cell-to-cell interactions, among others.

Although scholarly understanding of mesothelioma TME increasingly recognizes the pro-tumorigenic functions of stromal components compared to other tumor types, there remains a significant lack of information regarding the molecular characteristics of these cellular elements. A deeper understanding of stromal cells within the TME, as well as their complex crosstalk with immune cells, could be pivotal in defining a more precise biological profile of PM and, ultimately, in identifying novel therapeutic opportunities.

Dr. Marcella Barbarino
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • mesothelioma
  • tumor-associated stromal cells
  • immunotherapy
  • tumor microenvironment
  • cancer-associated fibroblast
  • mesenchymal stem cells
  • endothelial cells
  • cancer-associated adipocytes

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop